• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Jim Stommen

Articles by Jim Stommen

The MDD Interview: National telemedicine group's CEO says its time has come

Aug. 30, 2012
By Jim Stommen
Jon Linkous is CEO of the American Telemedicine Association (ATA; Washington), which bills itself as the largest membership-based organization in the world focusing exclusively on providing health and medical care through telecommunications technology. He has spoken and written extensively in the U.S. and in other countries on policy issues, emerging applications and market trends affecting telemedicine. Linkous has more than 20 years of experience in the nation's capital working in corporate and public sectors.
Read More

The MDD Interview: Even with gains against apnea, Coppola says, 'We have to do more'

Aug. 23, 2012
By Jim Stommen
Michael Coppola, MD, is chief medical officer and VP of medical affairs for NovaSom (Glen Burnie, Maryland). He also serves as president of the American Sleep Apnea Association, a patient advocacy group. Of obstructive sleep apnea, he says, "It's a big area, certainly one of the largest health problems in the United States."
Read More

The MDD Interview: Coppola sees company, association goals as same: Serve patients

Aug. 16, 2012
By Jim Stommen
Michael Coppola, MD, is chief medical officer and VP of medical affairs for NovaSom (Glen Burnie, Maryland). He also serves as president of the American Sleep Apnea Association, a patient advocacy group. Of obstructive sleep apnea, he says, "It's a big area, certainly one of the largest health problems in the United States."
Read More

Awarding an Oscar for best performance in raising awareness of prosthetic technologies

Aug. 14, 2012
By Jim Stommen
Oscar Pistorius didn’t win a medal in the just-concluded Olympic Games. Not a gold, not a silver, not a bronze. In fact, he finished last in his semifinal heat of the 400-meter run (I think they call it the 400-meter dash, although I can’t fathom any race that requires one full lap around the track being called a dash), and his South African relay team finished next-to-last in the finals of that event. But the 25-year-old Pistorius leaves quite a legacy behind in London, and not just because he became the first double-amputee athlete to compete against normal, able-bodied athletes...
Read More

The MDD Interview: Nash sees healthcare's mission as improving care while cutting costs

Aug. 2, 2012
By Jim Stommen
David B. Nash, MD, was named the founding dean of the Jefferson School of Population Health (JSPH; Philadelphia) in 2008, following an 18-year tenure on the faculty of Jefferson Medical College. JSPH provides innovative educational programming designed to develop healthcare leaders for the future. Its offerings include masters programs in public health, healthcare quality and safety, health policy and applied health economics. JSPH also offers a doctoral program in population health science.
Read More

The MDD Interview: Aspinall says diagnostics assure effective treatment of illnesses

July 26, 2012
By Jim Stommen
Mara Aspinall is president of Ventana Medical Systems (Tucson, Arizona), a maker of tissue-based cancer diagnostics and a member of the Roche Group. Prior to joining Ventana in September 2011, she was founder, president, and CEO of On-Q-ity, a start-up diagnostics company focused on circulating tumor cell technology. Prior to that, Aspinall spent 12 years with Genzyme, where she held senior leadership roles such as president of Genzyme Genetics and president of Genzyme Pharmaceuticals.
Read More

The MDD Interview: Aspinall: DxInsights aims at educating about role of diagnostics

July 19, 2012
By Jim Stommen
Mara Aspinall is president of Ventana Medical Systems (Tucson, Arizona), a maker of tissue-based cancer diagnostics and a member of the Roche Group. Prior to joining Ventana in September 2011, she was founder, president/CEO of On-Q-ity, a start-up diagnostics company focused on circulating tumor cell technology. Prior to that, Aspinall spent 12 years with Genzyme, where she held senior leadership roles as president of Genzyme Genetics and president of Genzyme Pharmaceuticals.
Read More

The MDD Interview: McHugh sees opportunities in a changing healthcare ecosystem

July 12, 2012
By Jim Stommen
Julie McHugh was appointed chief operating officer of Endo Health Solutions (Chadds Ford, Pennsylvania) in March 2010. Prior to joining Endo, she was CEO of Nora Therapeutics, a venture-backed biotech company focused on the treatment of infertility disorders.
Read More

The MDD Interview: Former pharma company Endo knee-deep in 'health solutions'

July 5, 2012
By Jim Stommen
Julie McHugh was appointed chief operating officer of Endo Health Solutions (Chadds Ford, Pennsylvania) in March 2010. Prior to joining Endo, she was CEO of Nora Therapeutics, a venture-backed biotech company focused on the treatment of infertility disorders.
Read More

The MDD Interview: Erdman optimistic about changing device approval approach

June 28, 2012
By Jim Stommen
Arthur Erdman, PhD, is the Richard C. Jordan Professor and a Morse Alumni Distinguished Teaching Professor of Mechanical Engineering at the University of Minnesota, specializing in mechanical design, bioengineering and product design. In July 2007 he was selected as the Director of the Medical Devices Center at the university. Erdman has published more than 325 technical papers, three books, holds over 30 patents, and shares with his former students nine Best Paper Awards at international conferences.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 … 31 32 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 20, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 18, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 17, 2025
  • Red blood cells in an artery with cholesterol

    In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol

    BioWorld
    In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
  • Enflonsia

    Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty

    BioWorld
    With the U.S. FDA’s approval of Enflonsia (clesrovimab) to prevent respiratory syncytial virus (RSV) infection lower respiratory tract disease in newborns and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe